Observational Study of REVIVE Samfilcon B Toric Contact Lenses for Astigmatism

This study is looking at REVIVE samfilcon B custom toric contact lenses for people with astigmatism (a common vision problem where the eye's front surface is curved unevenly). It's an observational study, meaning researchers will watch how the lenses perform in real-world use. They want to see how well people see with these lenses and how satisfied eye care professionals are with them. You might be able to join if you are 18 or older, can give informed consent, and have healthy eyes without active disease or allergies. The study aims to enroll about 30 participants, but its current status is unclear.

Study design
This is an observational study with an unclear status, planning to enroll about 30 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your eye care professional's satisfaction will be assessed about 14 days after your final lens fitting or adjustment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06785194

Revive Toric RWE Study

Not Yet Recruiting
Not specifiedAges 18+Observational
Bausch & Lomb Incorporated
~30 participants
Updated 2025-11-28 on ClinicalTrials.gov
What's tested:REVIVE samfilcon B custom toric contact lenses

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Investigator overall satisfaction as assessed by the Investigator Survey
Measured over Assessed 14 days ± 3 days after the final dispensing/refinement visit
Astigmatism
3 sites across 2 states
Florida2
Georgia1

Opens a ready-to-send draft in your own email app — review before sending.

  • Investigator overall satisfaction as assessed by the Investigator SurveyAssessed 14 days ± 3 days after the final dispensing/refinement visit

    (completed by the Investigator for each subject at 14 days ± 3 days after the final dispensing/refinement visit)